Home

The neuronal markers contents study in some infectious diseases

Written by Dyuizen I.V., Ivanis V.А., Mihailov А.С., Menchinskaya Е.С., Manzhulo I.V., Ogurtsova О.С.

  UDK: 616.831-02:616.9-074/076 | Pages: 27–30 | Full text PDF | Open PDF 

Annotation:

Background. Serum levels of such proteins as the S100, glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE) give an idea of the severity, depth and extent of the lesion of brain structures. Methods. In the serum of 20 patients with hemorrhagic fever with renal syndrome and chronic hepatitis C virus protein concentration was determined S100, GFAP and NSE. Results. The level of S100 in serum in hemorrhagic fever with renal syndrome has been raised 13 times; the concentration of GFAP did not differ from the control values, the content of NSE in 11 cases was increased by 5 times. S100 and GFAP levels in the serum of patients with chronic hepatitis C were close to normal values; the content of NSE in 11 patients was increased by 3 times. Conclusions. The presence of violations of the permeability of the blood-brain barrier, and neuropathology, possibly vascular and autoimmune origin that involves the cells of the neuroendocrine system in the pathogenesis of encephalopathy in hemorrhagic fever with renal syndrome and chronic hepatitis C virus.

Links to authors:

I.V. Dyuizen, V.А. Ivanis, А.С. Mihailov, Е.С. Menchinskaya, I.V. Manzhulo, О.С. Ogurtsova
Pacific State Medical University (2 Ostryakova Ave. Vladivostok 690950 Russian Federation)


1. Busygin S.N., Klink Yu.P., Bubnova I.D. The relation between serum S100 protein level and severity of encephalopathy in sepsis // Ural Medical Journal. 2012. No. 12. P. 126–129.
2. Viral hepatitis: clinical features, diagnosis, treatment / Yuschuk N.D., Klimova E.A., Znoyko O.O. [et al.] М.: GEOTAR-Media, 2012. 155p.
3. Hemorrhagic fever with renal syndrome: modern aspects of ecology, etiology, epidemiology, immunopathogenesis, diagnosis, and treatment clinics // Slonova R.A., Tkachenko E.A., Ivanis V.A. [et al.] Vladivostok: Primpolygrafkombinat, 2006, P. 96–196.
4. Evseev A.N. Hemorrhagic fever with renal syndrome: pathoand morphogenesis , macro- and microscopic examination. Khabarovsk: Omega-Press, 2010. 296 p.
5. Zhukova I.A., Aliferova V.M. Neuron specific enolase as a nonspecific marker of neurodegenerative process // Bulletin of Siberian Medicine. 2011. No. 2. P. 15–21.
6. Ignatova T.M., Aprosina Z.G., Serov V.V. [et al.] Extrahepatic manifestations of chronic HCV-infection // Russian Medical Journal. 2001. No. 2. P. 13–18.
7. Kaminskiy Yu.V. Clinical morphology of infectious diseases in Primorsky territory. Vladivostok: Medicine FE, 2011. 216 p.
8. Novikova L.B. Brain damage in hemorrhagic fever with renal syndrome in Bashkortostan: thesis abstract, MD. Perm, 2000. 41 p.
9. Shaytanova T.Yu., Saskin V.A., Nedashkovskiy E.V. Practical use of S100B protein in acute cerebral pathology // Bulletin of anestheology and resuscitation. 2014. No. 2. P. 63–71.
10. Bonetti B., Scardoni M., Monaco S. [et. al.] Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia // Virchows Arch. 1999. Vol. 434. P. 533–535.
11. Lu Yu, J. Hong Cui, Yu Jing Sun [et al.] Hantavirus infection of neurons in newborn mice and primary cultures induces f delayed HSP70 response and results in cell death // Abstracts of VIII international conference of HFRS, HPS and hantaviruses. Athens, Greece, 2010. P. 191.
12. Marcotic A. Clinic and laboratory findings of HFRS patients in South-East Europe // Abstracts of IX international conference of HFRS, HPS and hantaviruses. Beijing, China, 2013. P. 13.
13. Manigold T., Vial P. Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology // Swiss Med. Wkly. 2014. Vol. 144, No. 13937. P. 1–10.
14. Origgi L., Vanoli M., Carbone A. [et. al.] Central nervous system involvement in patients with HCV-related cryoglobulinemia // Am. J. Med. Sci. 1998. Vol. 315. P. 208–210.
15. Thomas H.C., Torok M.E., Forton D.M. [et. al.] Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C // Journal of Hepatology. 1999. Vol. 31, No. 1. P. 152–159.

PUBLISHER: "MEDITSYNA DV"

Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.